Search research articles
Contact Us
Filters
Showing results (341-350 of 428) with videos related to
Page
of 43
Sort By:
Cancer Treatment Reports
|
January 1, 1981
Biochemical pharmacology in medical oncology
E Frei, M B Garnick, W D Ensminger, et al.
Cancer
|
October 11, 1992
Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer
T J Lynch, J R Clark, L A Kalish, et al.
Journal of Hematotherapy
|
January 1, 1993
The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy
A D Elias, L Ayash, I Tepler, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1994
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age
K Antman, L Ayash, A Elias, et al.
Blood
|
December 1, 1977
High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement
A T Skarin, K S Zuckerman, S W Pitman, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo
E A Sotomayor, B A Teicher, G N Schwartz, et al.
Cancer Research
|
November 15, 1987
Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II)
A Rosowsky, J E Wright, C A Cucchi, et al.
Anti-Cancer Drug Design
|
June 7, 2002
Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone
M Weigand, G Hartung, J Roboz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 23, 2002
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program
A D Elias, J Ibrahim, P Richardson, et al.
National Cancer Institute Monograph
|
April 1, 1981
High-dose methotrexate in osteogenic sarcoma
N Jaffe, M P Link, D Cohen, et al.
Page
of 43
Search research articles
Search
Showing results (341-350 of 428) with videos related to
Sort By:
Page
of 43
Cancer Treatment Reports
|
January 1, 1981
Biochemical pharmacology in medical oncology
E Frei, M B Garnick, W D Ensminger, et al.
Cancer
|
October 11, 1992
Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer
T J Lynch, J R Clark, L A Kalish, et al.
Journal of Hematotherapy
|
January 1, 1993
The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy
A D Elias, L Ayash, I Tepler, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1994
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age
K Antman, L Ayash, A Elias, et al.
Blood
|
December 1, 1977
High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement
A T Skarin, K S Zuckerman, S W Pitman, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo
E A Sotomayor, B A Teicher, G N Schwartz, et al.
Cancer Research
|
November 15, 1987
Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II)
A Rosowsky, J E Wright, C A Cucchi, et al.
Anti-Cancer Drug Design
|
June 7, 2002
Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone
M Weigand, G Hartung, J Roboz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 23, 2002
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program
A D Elias, J Ibrahim, P Richardson, et al.
National Cancer Institute Monograph
|
April 1, 1981
High-dose methotrexate in osteogenic sarcoma
N Jaffe, M P Link, D Cohen, et al.
Page
of 43